• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

B7-H4单抗3C8的纯化及对肿瘤免疫逃逸的阻断作用研究

陈亚莉, 李安琪, 张宁玥, 章良

陈亚莉, 李安琪, 张宁玥, 章良. B7-H4单抗3C8的纯化及对肿瘤免疫逃逸的阻断作用研究[J]. 中国药科大学学报, 2017, 48(4): 461-468. DOI: 10.11665/j.issn.1000-5048.20170411
引用本文: 陈亚莉, 李安琪, 张宁玥, 章良. B7-H4单抗3C8的纯化及对肿瘤免疫逃逸的阻断作用研究[J]. 中国药科大学学报, 2017, 48(4): 461-468. DOI: 10.11665/j.issn.1000-5048.20170411
CHEN Yali, LI Anqi, ZHANG Ningyue, ZHANG Liang. Purification of monoclonal anti-B7-H4 antibody and the blockade of B7-H4-mediated tumor immune evasion by the antibody[J]. Journal of China Pharmaceutical University, 2017, 48(4): 461-468. DOI: 10.11665/j.issn.1000-5048.20170411
Citation: CHEN Yali, LI Anqi, ZHANG Ningyue, ZHANG Liang. Purification of monoclonal anti-B7-H4 antibody and the blockade of B7-H4-mediated tumor immune evasion by the antibody[J]. Journal of China Pharmaceutical University, 2017, 48(4): 461-468. DOI: 10.11665/j.issn.1000-5048.20170411

B7-H4单抗3C8的纯化及对肿瘤免疫逃逸的阻断作用研究

基金项目: 国家自然科学基金资助项目(No.31370872)

Purification of monoclonal anti-B7-H4 antibody and the blockade of B7-H4-mediated tumor immune evasion by the antibody

  • 摘要: 采用Protein G亲和色谱及DEAE阴离子交换柱色谱分离纯化精制鼠源性B7-H4单克隆抗体3C8,结合流式检测可与B7-H4/293T转基因细胞株结合的目标抗体组分,获得了纯化的鼠源性B7-H4单克隆抗体3C8。反相柱色谱检测其纯度为93%,SDS-PAGE凝胶电泳鉴定证明经过两步柱色谱,目标抗体的纯度大大提高。流式细胞术检测发现3C8只与B7-H4/293T转基因细胞株结合,不与Mock/293T细胞结合,并且3C8也不与B7家族其他成员的转基因细胞株结合。激光共聚焦实验显示3C8可特异性染色B7-H4/293T转基因细胞,Western blot实验发现,以3C8作为一抗,B7-H4/293T转基因细胞有阳性条带而Mock/293T细胞没有条带。用3C8作为一抗进行免疫组化,结果显示,前列腺癌和肾癌组织特异性高表达B7-H4分子,而前列腺癌旁组织和肾癌癌旁组织B7-H4呈阴性表达。T细胞体外实验显示,B7-H4-Ig可特异性与活化T细胞结合,但3C8可阻断这种结合作用,并可逆转T细胞增殖抑制作用及T细胞因子分泌抑制作用。
    Abstract: The purified 3C8 was obtained by two step column purification, including Protein G affinity purification and DEAE anion exchange purification. The purity of purified 3C8 was about 93% when analyzed by reverse column. SDS-PAGE showed that the purity of 3C8 was increased greatly by two step purification. By flowcytometry we found that 3C8 specifically binded with B7-H4/293T cells and did not bind with Mock/293T cells, moreover 3C8 did not bind with other B7 family members transgene cells. In confocal experiment 3C8 could specifically stained B7-H4/293T cells. In Western blot only B7-H4/293T cells showed positive band while Mock/293T cells showed negative result. The result of immunohistochemistry showed that B7-H4 was highly expressed in prostate cancer and renal cell carcinoma, while para-cancer tissues did not express B7-H4. The T cell proliferation experiment showed that B7-H4-Ig could bind to activate T cells and inhibit T cell proliferation, while 3C8 could block the binding of B7-H4-Ig and reverse the T cell proliferation inhibition effect of B7-H4-Ig by CFSE and CCK8 assay. The cytokine IFN-γ and IL-2 secreted by activating T cells was decreased by B7-H4-Ig and 3C8 could reverse the effect of B7-H4-Ig.
  • [1] Bretscher PA.A two-step,two-signal model for the primary activation of precursor helper T cells[J].Proc Natl Acad Sci U S A,1999,96(1):185-190.
    [2] Schildberg FA,Klein SR,Freeman GJ,et al.Coinhibitory pathways in the B7-CD28 ligand-receptor family[J].Immunity,2016,44(5):955-972.
    [3] Swaika A,Hammond WA,Joseph RW.Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy[J].Mol Immunol,2015,67(2 Pt A):4-17.
    [4] Sica GL,Choi IH,Zhu G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity,2003,18(6):849-861.
    [5] Prasad DV,Richards S,Mai XM,et al.B7S1,a novel B7 family member that negatively regulates T cell activation[J].Immunity,2003,18(6):863-873.
    [6] Zang X,Loke P,Kim J,et al.B7x:a widely expressed B7 family member that inhibits T cell activation[J].Proc Natl Acad Sci U S A,2003,100(18):10388-10392.
    [7] Awadallah NS,Shroyer KR,Langer DA,et al.Detection of B7-H4 and p53 in pancreatic cancer:potential role as a cytological diagnostic adjunct[J].Pancreas,2008,36(2):200-206.
    [8] Miyatake T,Tringler B,Liu W,et al.B7-H4(DD-O110)is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration[J].Gynecol Oncol,2007,106(1):119-127.
    [9] Podojil JR,Miller SD.Potential targeting of B7-H4 for the treatment of cancer[J].Immunol Rev,2017,276(1):40-51.
    [10] Ni L,Dong C.New B7 family checkpoints in human cancers[J].Mol Cancer Ther,2017,16(7):1203-1211.
    [11] MacGregor HL,Ohashi PS.Molecular pathways:evaluating the potential for B7-H4 as an immunoregulatory target[J].Clin Cancer Res,2017,23(12):2934-2941.
    [12] Jeon H,Vigdorovich X,Garrett-Thomson SC,et al.Structure and cancer immunotherapy of the B7 family member B7x[J].Cell Rep,2014,9(3):1089-1098.
    [13] Dangaj D,Lanitis E,Zhao A,et al.Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses[J].Cancer Res,2013,73(15):4820-4829.
    [14] Dangaj D,Scholler N.Isolation and validation of Anti-B7-H4 scFvs from an ovarian cancer scFv yeast-display library[J].Methods Mol Biol,2015,1319:37-49.
    [15] Leong SR,Liang WC,Wu Y,et al.An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer[J].Mol Pharm,2015,12(6):1717-1729.
计量
  • 文章访问数:  635
  • HTML全文浏览量:  1
  • PDF下载量:  1389
  • 被引次数: 0
出版历程
  • 刊出日期:  2017-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭